[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Proteomics Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service (Instrumentation Technologies, Reagents & Consumables, and Software & Services), Application (Clinical Diagnostics, Drug Discovery & Development, and Others), End User (Pharmaceutical & Biotechnology Companies, Research & Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)?

March 2024 | 150 pages | ID: P59BDC9320A8EN
The Insight Partners

US$ 5,190.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our new research study on “Proteomics Market Forecast to 2030 – COVID-19 Impact and Global Analysis – by Product & Service, Application, and End User,” the market is anticipated to grow from US$ 27.07 billion in 2022 and is projected to reach US$ 75.03 billion by 2030; it is expected to register a CAGR of 13.6% during 2022–2030. Market growth is attributed to the proliferating cases of chronic diseases and the growing prominence of nano proteomics. Growing technological advancements and R&D expenditure will likely provide growth opportunities for the proteomics market. However, the high costs of instruments and the dearth of skilled personnel hinder the growth of the proteomics market.

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation. In the pharmaceutical field, proteomics studies drug effects or the mechanism of toxicity. They are also widely used to identify and confirm the effectiveness of biomarkers.

North America accounted for a major share of the global proteomics market in 2022. The North American proteomics market is segmented into the US, Canada, and Mexico. The key factors driving the market growth in this region is the increasing investments in the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. Partnerships and collaborations between major regional companies also contribute to the market expansion in the region. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Also, proteomics research is at its peak in countries like the US.

Growing Technological Advancements and R&D Expenditure to Provide Market Opportunities in the Future

Manufacturers in the proteomics industry are focused on providing new methods and devices for disease diagnosis. Companies such as Agilent Technologies, Inc. have recognized the advantages of using technology out-licensing strategies to focus on developing products for protein analysis. The absolute quantification of protein-based diagnostics was made possible through the use of proteomics technology. Key proteomic services and other technologies, including microarray, X-ray crystallography, spectroscopic techniques, chromatography, electrophoresis, and surface plasma resonance systems, form the foundation of the proteomics market.

The increasing investments in research and development in proteomics are fostering market growth. The US National Institutes of Health (NIH) gave US$ 37 billion for biomedical research. This funding will aid in studying the fundamental mechanisms of disease development, identifying biomarkers that indicate the presence of a disease, or identifying the gene or protein that causes the disease. The Novo Nordisk Foundation granted the University of Copenhagen a grant of up to US$ 1.5 million to build a mass spectrometry facility, an important step toward protein research. The market quickly gained momentum after the outbreak of COVID-19.

Key players are crucial in improving people's access to quality healthcare and medicines in developing countries, which also expands their economic prospects, and they are also working to increase economic opportunities by creating more jobs, making significant investments, influencing public policy, and providing trainings. The pharmaceutical industry has a significant impact on the growth of economic opportunities in developing countries. In recent years, pharmaceutical companies have achieved excellent financial results. For example, Thermo Fisher Scientific, Inc. posted record profits last year, and future performance is predicted to be even better. The market will continue to flourish as several biopharmaceutical companies are emerging as key players and various R&D activities are being conducted, thereby providing growth opportunities for the global market.

Product & Service -Based Insights

Based on product & service, the proteomics market is divided into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is likely to register the highest CAGR of 14.1% during 2022–2030.

Reagents & kits, consumables, and strips are increasingly used for studying various biological materials in research universities, research institutions, and other areas. Government initiatives in the field of proteomics and genomics are propelling research activities in disease diagnostics. Technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, are also propelling the demand for reagents and consumables. These factors are contributing to the growing proteomics market size for the segment.

Application -Based Insights

The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is expected to register the highest CAGR of 14.4% during 2022–2030.

End User -Based Insights

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022–2030.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.
  • In January 2022, Seer, Inc. announced the debut of the Centers of Excellence program and the commercial release of the Proteograph Product Suite. The Proteograph Product Suite provides unbiased, unmatched access to the proteome. The approach uses uniquely designed nanoparticles to produce a breakthrough product that enables rapid, thorough, and unbiased large-scale proteomics.
  • In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.
  • In February 2021, Poochon Scientific, LLC acquired a new Thermo Orbitrap Exploris 240 mass spectrometer that has BioPharma option and FAIMS Pro interface. It is a versatile, new-generation, high-resolution mass spectrometer that offers exceptional performance for proteomics, metabolomics, and biopharmaceutical characterization.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the proteomics market report.
1. INTRODUCTION

1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
  1.3.1 Proteomics Market - By Instrument
  1.3.2 Proteomics Market - By Reagents
  1.3.3 Proteomics Market - By Services and Software
  1.3.4 Proteomics Market - By Application
  1.3.5 Proteomics Market - By Region
    1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
  4.2.1 North America - Pest Analysis
  4.2.2 Europe - Pest Analysis
  4.2.3 Asia-Pacific - Pest Analysis
  4.2.4 Middle East and Africa - Pest Analysis
  4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

7.1. OVERVIEW
7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
7.3. SPECTROSCOPY
  7.3.1. Overview
  7.3.2. Spectroscopy Market Forecast and Analysis
  7.3.3. Mass Spectroscopy Market
    7.3.3.1. Overview
    7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
  7.3.4. NMR Spectroscopy Market
    7.3.4.1. Overview
    7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
  7.3.5. Circular Dichroism (CD) Spectroscopy Market
    7.3.5.1. Overview
    7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
7.4. CHROMATOGRAPHY
  7.4.1. Overview
  7.4.2. Chromatography Market Forecast and Analysis
  7.4.3. HPLC Market
    7.4.3.1. Overview
    7.4.3.2. HPLC Market Forecast and Analysis
  7.4.4. Ion Chromatography Market
    7.4.4.1. Overview
    7.4.4.2. Ion Chromatography Market Forecast and Analysis
  7.4.5. Ion Chromatography Market
    7.4.5.1. Overview
    7.4.5.2. Ion Chromatography Market Forecast and Analysis
  7.4.6. Supercritical Fluid Chromatography Market
    7.4.6.1. Overview
    7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
7.5. ELECTROPHORESIS
  7.5.1. Overview
  7.5.2. Electrophoresis Market Forecast and Analysis
  7.5.3. Gel Electrophoresis Market
    7.5.3.1. Overview
    7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
  7.5.4. Capillary Electrophoresis Market
    7.5.4.1. Overview
    7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
7.6. PROTEIN MICROARRAYS
  7.6.1. Overview
  7.6.2. Protein Microarrays Market Forecast and Analysis
  7.6.3. Biochips Market
    7.6.3.1. Overview
    7.6.3.2. Biochips Market Forecast and Analysis
  7.6.4. Microarray Instruments Market
    7.6.4.1. Overview
    7.6.4.2. Microarray Instruments Market Forecast and Analysis
7.7. X-RAY CRYSTALLOGRAPHY
  7.7.1. Overview
  7.7.2. X-Ray Crystallography Market Forecast and Analysis
7.8. SURFACE PLASMON RESONANCE
  7.8.1. Overview
  7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
7.9. PROTEIN FRACTIONATION
  7.9.1. Overview
  7.9.2. Protein Fractionation Market Forecast and Analysis
7.10. OTHER INSTRUMENT
  7.10.1. Overview
  7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

8.1. OVERVIEW
8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY REAGENTS
  8.3.1. Overview
  8.3.2. Immunoassay Reagents Market Forecast and Analysis
8.4. SPECTROSCOPY REAGENTS
  8.4.1. Overview
  8.4.2. Spectroscopy Reagents Market Forecast and Analysis
8.5. CHROMATOGRAPHY REAGENTS
  8.5.1. Overview
  8.5.2. Chromatography Reagents Market Forecast and Analysis
8.6. PROTEIN MICROARRAY REAGENTS
  8.6.1. Overview
  8.6.2. Protein Microarray Reagents Market Forecast and Analysis
8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
  8.7.1. Overview
  8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
8.8. ELECTROPHORESIS REAGENTS
  8.8.1. Overview
  8.8.2. Electrophoresis Reagents Market Forecast and Analysis
8.9. PROTEIN FRACTIONATION REAGENTS
  8.9.1. Overview
  8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

9.1. OVERVIEW
9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
9.3. SERVICES
  9.3.1. Overview
  9.3.2. Services Market Forecast and Analysis
  9.3.3. Protein Identification Services Market
    9.3.3.1. Overview
    9.3.3.2. Protein Identification Services Market Forecast and Analysis
  9.3.4. Quantitative Proteomics Services Market
    9.3.4.1. Overview
    9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
  9.3.5. Protein Purification Services Market
    9.3.5.1. Overview
    9.3.5.2. Protein Purification Services Market Forecast and Analysis
  9.3.6. Protein Separation Services Market
    9.3.6.1. Overview
    9.3.6.2. Protein Separation Services Market Forecast and Analysis
  9.3.7. Protein Sequencing Services Market
    9.3.7.1. Overview
    9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
  9.3.8. Others Services Market
    9.3.8.1. Overview
    9.3.8.2. Others Services Market Forecast and Analysis
9.4. SOFTWARE
  9.4.1. Overview
  9.4.2. Software Market Forecast and Analysis
  9.4.3. Bioinformatics Services Market
    9.4.3.1. Overview
    9.4.3.2. Bioinformatics Services Market Forecast and Analysis
  9.4.4. Bioinformatics Tools Market
    9.4.4.1. Overview
    9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
  9.4.5. Bioinformatics Databases Market
    9.4.5.1. Overview
    9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

10.1. OVERVIEW
10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. CLINICAL DIAGNOSTICS
  10.3.1. Overview
  10.3.2. Clinical Diagnostics Market Forecast and Analysis
10.4. DRUG DISCOVERY
  10.4.1. Overview
  10.4.2. Drug Discovery Market Forecast and Analysis
10.5. OTHER APPLICATIONS
  10.5.1. Overview
  10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
  11.1.1 North America Proteomics Market Overview
  11.1.2 North America Proteomics Market Forecasts and Analysis
  11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
  11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
  11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
  11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
  11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
    11.1.7.1 United States Proteomics Market
      11.1.7.1.1 United States Proteomics Market by Instrument
      11.1.7.1.2 United States Proteomics Market by Reagents
      11.1.7.1.3 United States Proteomics Market by Services and Software
      11.1.7.1.4 United States Proteomics Market by Application
    11.1.7.2 Canada Proteomics Market
      11.1.7.2.1 Canada Proteomics Market by Instrument
      11.1.7.2.2 Canada Proteomics Market by Reagents
      11.1.7.2.3 Canada Proteomics Market by Services and Software
      11.1.7.2.4 Canada Proteomics Market by Application
    11.1.7.3 Mexico Proteomics Market
      11.1.7.3.1 Mexico Proteomics Market by Instrument
      11.1.7.3.2 Mexico Proteomics Market by Reagents
      11.1.7.3.3 Mexico Proteomics Market by Services and Software
      11.1.7.3.4 Mexico Proteomics Market by Application
11.2. EUROPE
  11.2.1 Europe Proteomics Market Overview
  11.2.2 Europe Proteomics Market Forecasts and Analysis
  11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
  11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
  11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
  11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
  11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
    11.2.7.1 Germany Proteomics Market
      11.2.7.1.1 Germany Proteomics Market by Instrument
      11.2.7.1.2 Germany Proteomics Market by Reagents
      11.2.7.1.3 Germany Proteomics Market by Services and Software
      11.2.7.1.4 Germany Proteomics Market by Application
    11.2.7.2 France Proteomics Market
      11.2.7.2.1 France Proteomics Market by Instrument
      11.2.7.2.2 France Proteomics Market by Reagents
      11.2.7.2.3 France Proteomics Market by Services and Software
      11.2.7.2.4 France Proteomics Market by Application
    11.2.7.3 Italy Proteomics Market
      11.2.7.3.1 Italy Proteomics Market by Instrument
      11.2.7.3.2 Italy Proteomics Market by Reagents
      11.2.7.3.3 Italy Proteomics Market by Services and Software
      11.2.7.3.4 Italy Proteomics Market by Application
    11.2.7.4 Spain Proteomics Market
      11.2.7.4.1 Spain Proteomics Market by Instrument
      11.2.7.4.2 Spain Proteomics Market by Reagents
      11.2.7.4.3 Spain Proteomics Market by Services and Software
      11.2.7.4.4 Spain Proteomics Market by Application
    11.2.7.5 United Kingdom Proteomics Market
      11.2.7.5.1 United Kingdom Proteomics Market by Instrument
      11.2.7.5.2 United Kingdom Proteomics Market by Reagents
      11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
      11.2.7.5.4 United Kingdom Proteomics Market by Application
    11.2.7.6 Rest of Europe Proteomics Market
      11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
      11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
      11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
      11.2.7.6.4 Rest of Europe Proteomics Market by Application
11.3. ASIA-PACIFIC
  11.3.1 Asia-Pacific Proteomics Market Overview
  11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
  11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
  11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
  11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
  11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
  11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
    11.3.7.1 Australia Proteomics Market
      11.3.7.1.1 Australia Proteomics Market by Instrument
      11.3.7.1.2 Australia Proteomics Market by Reagents
      11.3.7.1.3 Australia Proteomics Market by Services and Software
      11.3.7.1.4 Australia Proteomics Market by Application
    11.3.7.2 China Proteomics Market
      11.3.7.2.1 China Proteomics Market by Instrument
      11.3.7.2.2 China Proteomics Market by Reagents
      11.3.7.2.3 China Proteomics Market by Services and Software
      11.3.7.2.4 China Proteomics Market by Application
    11.3.7.3 India Proteomics Market
      11.3.7.3.1 India Proteomics Market by Instrument
      11.3.7.3.2 India Proteomics Market by Reagents
      11.3.7.3.3 India Proteomics Market by Services and Software
      11.3.7.3.4 India Proteomics Market by Application
    11.3.7.4 Japan Proteomics Market
      11.3.7.4.1 Japan Proteomics Market by Instrument
      11.3.7.4.2 Japan Proteomics Market by Reagents
      11.3.7.4.3 Japan Proteomics Market by Services and Software
      11.3.7.4.4 Japan Proteomics Market by Application
    11.3.7.5 South Korea Proteomics Market
      11.3.7.5.1 South Korea Proteomics Market by Instrument
      11.3.7.5.2 South Korea Proteomics Market by Reagents
      11.3.7.5.3 South Korea Proteomics Market by Services and Software
      11.3.7.5.4 South Korea Proteomics Market by Application
    11.3.7.6 Rest of Asia-Pacific Proteomics Market
      11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
      11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
      11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
      11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
11.4. MIDDLE EAST AND AFRICA
  11.4.1 Middle East and Africa Proteomics Market Overview
  11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
  11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
  11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
  11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
  11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
  11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
    11.4.7.1 South Africa Proteomics Market
      11.4.7.1.1 South Africa Proteomics Market by Instrument
      11.4.7.1.2 South Africa Proteomics Market by Reagents
      11.4.7.1.3 South Africa Proteomics Market by Services and Software
      11.4.7.1.4 South Africa Proteomics Market by Application
    11.4.7.2 Saudi Arabia Proteomics Market
      11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
      11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
      11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
      11.4.7.2.4 Saudi Arabia Proteomics Market by Application
    11.4.7.3 U.A.E Proteomics Market
      11.4.7.3.1 U.A.E Proteomics Market by Instrument
      11.4.7.3.2 U.A.E Proteomics Market by Reagents
      11.4.7.3.3 U.A.E Proteomics Market by Services and Software
      11.4.7.3.4 U.A.E Proteomics Market by Application
    11.4.7.4 Rest of Middle East and Africa Proteomics Market
      11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
      11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
      11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
      11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
11.5. SOUTH AND CENTRAL AMERICA
  11.5.1 South and Central America Proteomics Market Overview
  11.5.2 South and Central America Proteomics Market Forecasts and Analysis
  11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
  11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
  11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
  11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
  11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
    11.5.7.1 Brazil Proteomics Market
      11.5.7.1.1 Brazil Proteomics Market by Instrument
      11.5.7.1.2 Brazil Proteomics Market by Reagents
      11.5.7.1.3 Brazil Proteomics Market by Services and Software
      11.5.7.1.4 Brazil Proteomics Market by Application
    11.5.7.2 Argentina Proteomics Market
      11.5.7.2.1 Argentina Proteomics Market by Instrument
      11.5.7.2.2 Argentina Proteomics Market by Reagents
      11.5.7.2.3 Argentina Proteomics Market by Services and Software
      11.5.7.2.4 Argentina Proteomics Market by Application
    11.5.7.3 Rest of South and Central America Proteomics Market
      11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
      11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
      11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
      11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America

13. INDUSTRY LANDSCAPE

13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

14.1. THERMO FISHER SCIENTIFIC INC.
  14.1.1. Key Facts
  14.1.2. Business Description
  14.1.3. Products and Services
  14.1.4. Financial Overview
  14.1.5. SWOT Analysis
  14.1.6. Key Developments
14.2. BIO-RAD LABORATORIES, INC.
  14.2.1. Key Facts
  14.2.2. Business Description
  14.2.3. Products and Services
  14.2.4. Financial Overview
  14.2.5. SWOT Analysis
  14.2.6. Key Developments
14.3. AGILENT TECHNOLOGIES
  14.3.1. Key Facts
  14.3.2. Business Description
  14.3.3. Products and Services
  14.3.4. Financial Overview
  14.3.5. SWOT Analysis
  14.3.6. Key Developments
14.4. DANAHER
  14.4.1. Key Facts
  14.4.2. Business Description
  14.4.3. Products and Services
  14.4.4. Financial Overview
  14.4.5. SWOT Analysis
  14.4.6. Key Developments
14.5. PERKINELMER INC.
  14.5.1. Key Facts
  14.5.2. Business Description
  14.5.3. Products and Services
  14.5.4. Financial Overview
  14.5.5. SWOT Analysis
  14.5.6. Key Developments
14.6. MERCK KGAA
  14.6.1. Key Facts
  14.6.2. Business Description
  14.6.3. Products and Services
  14.6.4. Financial Overview
  14.6.5. SWOT Analysis
  14.6.6. Key Developments
14.7. LUMINEX CORPORATION
  14.7.1. Key Facts
  14.7.2. Business Description
  14.7.3. Products and Services
  14.7.4. Financial Overview
  14.7.5. SWOT Analysis
  14.7.6. Key Developments
14.8. GENERAL ELECTRIC COMPANY
  14.8.1. Key Facts
  14.8.2. Business Description
  14.8.3. Products and S


More Publications